Physician profile
William M Johnson
NPI 1437179587
$9,727.43
in general payments reported to CMS, 2019-2025
40 companies · $2.21 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,839 · 2020: $488 · 2021: $922 · 2022: $1,207 · 2023: $1,651 · 2024: $618 · 2025: $2.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,271.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $3,827.68 | 2019 | |
| Pfizer INC. | $721.35 | 2019-2024 | |
| Abbvie INC. | $619.21 | 2019-2023 | |
| Therapeuticsmd, INC. | $514.87 | 2019-2022 | |
| Astellas Pharma US INC | $478.89 | 2019-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $397.85 | 2023-2024 | Gemtesa, Myfembree |
| Myriad Women'S Health, INC. | $322.66 | 2023 | Myrisk |
| Amgen INC. | $287.21 | 2019-2024 | Prolia, Evenity |
| Urovant Sciences INC | $259.19 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $227.10 | 2021-2025 | |
| Evofem Biosciences, INC. | $202.35 | 2021-2022 | |
| Medtronic, INC. | $197.61 | 2022-2024 | Ligasure |
| Bayer Healthcare Pharmaceuticals INC. | $156.85 | 2019-2024 | |
| Caldera Medical, INC | $148.08 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $135.53 | 2023 | Seglentis |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.